Order number: 342C.1
Part number: AC100008563
Widely applied in chemical workflows, the HPLC column NUCLEODUR® C 8 Gravity offers exceptional performance for reversed-phase separations. Its high-density C 8 phase, based on high-purity NUCLEODUR® silica gel, provides excellent pH stability, making it ideal for use with basic and ionizable analytes. The endcapped nature of this column suppresses unwanted polar interactions, enhancing its suitability for LC/MS applications. With a particle size of 3 μm and a specific surface area of 340 m²/g, this column delivers efficient separations while maintaining pressure stability up to 600 bar. Recommended applications include the separation of pharmaceuticals, herbicides, and immunosuppressants, among others.
| Name | Value | |
|---|---|---|
| Phase | : | C 8 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | HPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L7 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 0.53 ml |
| Particle size | : | 3 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8 |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification |
| Pressure stability | : | 600 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 75 x 3 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
© 2026 Copyright. All Rights Reserved.
© 2026 Copyright. All Rights Reserved.